Adeno-associated virus vectors: activity and applications in the CNS

被引:124
|
作者
Peel, AL
Klein, RL
机构
[1] Buck Ctr Res Aging, Novato, CA 94948 USA
[2] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA
关键词
adeno-associated virus (AAV); disease-modeling; gene therapy; gene transfer; neurodegenerative disease; neurotrophic factor;
D O I
10.1016/S0165-0270(00)00183-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Transgenic strategies are useful for functional studies and they may also lead to novel therapies. Controlling transgene expression in defined cell populations over time is increasingly important for both functional and gene therapy experiments. The adeno-associated virus (AAV) vector may provide sufficient spatio-temporal control of gene expression for these purposes. This paper reviews in vivo somatic gene transfer methodology using AAV. Advantageous features of this system include neuronal gene expression that is: (1) efficient; (2) long-lived; and (3) non-toxic. Thus, AAV-mediated gene transfer is a good method for functional genomic research. From characterizing vector activity in the brain using different combinations of promoters and transgenes in the mid to late 1990s, researchers continue to discover novel uses of AAV for both basic and clinical neuroscience. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:95 / 104
页数:10
相关论文
共 50 条
  • [41] Random and targeted integration of adeno-associated virus vectors
    Russell, David W.
    BLOOD CELLS MOLECULES AND DISEASES, 2008, 40 (02) : 282 - 283
  • [42] Gene therapy using adeno-associated virus vectors
    Muramatsu, Shin-ichi
    CANCER SCIENCE, 2018, 109 : 1200 - 1200
  • [43] Gene targeting in vivo by adeno-associated virus vectors
    Daniel G Miller
    Pei-Rong Wang
    Lisa M Petek
    Roli K Hirata
    Mark S Sands
    David W Russell
    Nature Biotechnology, 2006, 24 : 1022 - 1026
  • [44] Adeno-associated virus vectors for gene transfer to the brain
    Okada, T
    Nomoto, T
    Shimazaki, K
    Wang, LJ
    Lu, YY
    Matsushita, T
    Mizukami, H
    Urabe, M
    Hanazono, Y
    Kume, A
    Muramatsu, S
    Nakano, I
    Ozawa, K
    METHODS, 2002, 28 (02) : 237 - 247
  • [45] Engineering adeno-associated virus vectors for gene therapy
    Chengwen Li
    R. Jude Samulski
    Nature Reviews Genetics, 2020, 21 : 255 - 272
  • [46] Adeno-associated viral vectors
    Lehtonen, E
    Tenenbaum, L
    VIRAL VECTORS FOR TREATING DISEASES OF THE NERVOUS SYSTEM, 2003, 55 : 65 - 98
  • [47] Chimeric herpes simplex virus/adeno-associated virus amplicon vectors
    Glauser, Daniel L.
    Ackermann, Mathias
    Saydam, Okay
    Fraefel, Cornel
    CURRENT GENE THERAPY, 2006, 6 (03) : 315 - 324
  • [48] Research Status and Applications of Adeno-Associated Virus
    Xia, Ke
    Liu, Shuangling
    Wu, Zhenkun
    Jiang, Jian-Hui
    CHEMBIOCHEM, 2025,
  • [49] Immune responses to adeno-associated virus and its recombinant vectors
    J Y Sun
    V Anand-Jawa
    S Chatterjee
    K K Wong
    Gene Therapy, 2003, 10 : 964 - 976
  • [50] Immune responses to adeno-associated virus and its recombinant vectors
    Sun, JY
    Anand-Jawa, V
    Chatterjee, S
    Wong, KK
    GENE THERAPY, 2003, 10 (11) : 964 - 976